Hemostatic Disorders: all 514 studies
Page 5 of 6. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.
- Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH)CompletedNCT01752725Not applicable
- Hemodilution and Coagulopathy With 3 ColloidsCompletedNCT01727830
- Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia ACompletedNCT01692925Phase 1
- Estradiol vs Lysteda in Treatment of Heavy Menstrual BleedingStatus unknownNCT01659008Not applicable
- Chronology of Occult and Gross Coagulopathy in Burn PatientsCompletedNCT01638481
- A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia SubjectsTerminatedNCT01631942Phase 1
- European Transfusion Practice and Outcome StudyCompletedNCT01604083
- Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCompletedNCT01601613Phase 2
- Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture ReconstructionCompletedNCT01601457Phase 2
- An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis PatientsCompletedNCT01590823Phase 1
- Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy VolunteersCompletedNCT01589666Phase 1
- Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain InjuryCompletedNCT01589172
- Anfibatide Phase 1 Clinical Trial in Healthy VolunteersCompletedNCT01588132Phase 1
- Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT01586936
- Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing SurgeryCompletedNCT01579968
- Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical PracticeCompletedNCT01579955
- Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral HaemorrhageCompletedNCT01566786Phase 2
- Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell TransplantationTerminatedNCT01564563Phase 2
- Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma PatientsCompletedNCT01563523Phase 2
- Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy VolunteersCompletedNCT01563471Phase 1
- Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver TransplantationCompletedNCT01563458Phase 2
- Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral HaemorrhageCompletedNCT01563445Phase 2
- Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial HepatectomyCompletedNCT01562821Phase 2
- Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding StateCompletedNCT01562587Phase 1
- Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart DiseaseCompletedNCT01562574Phase 3
- Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding StateCompletedNCT01562457Phase 1
- Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell TransplantationCompletedNCT01562158Phase 2
- Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of ThromboelastographyCompletedNCT01561924Phase 1
- Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male SubjectsCompletedNCT01561417Phase 1
- Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major SurgeryCompletedNCT01561391Phase 4
- Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese SubjectsCompletedNCT01555749Phase 1
- RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen PlasmaTerminatedNCT01545635Phase 3
- Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing CountriesCompletedNCT01503567
- Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.CompletedNCT01487837Phase 4
- Observational Registry of the Treatment of Glanzmann's ThrombastheniaCompletedNCT01476423
- Study to Determine the Accuracy of Prothrombin Time of Warfarinised BloodCompletedNCT01375725
- A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia ACompletedNCT01365520Phase 1
- Study to Test the Accuracy of a Prototype Handheld PT/INR DeviceStatus unknownNCT01349712
- Education Program for Patients Receiving Oral AnticoagulationStatus unknownNCT01339611Not applicable
- Survey Evaluating the Psychosocial Effects of Living With HaemophiliaCompletedNCT01322620
- Study of the Pathophysiological Mechanisms Involved in Bleeding EventsCompletedNCT01314560Not applicable
- Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII DeficiencyCompletedNCT01312636
- Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B PatientsCompletedNCT01288391Phase 1
- Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired HaemophiliaCompletedNCT01285089
- Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male SubjectsCompletedNCT01272206Phase 1
- Evaluation of Menses in Congenital Bleeding DisordersStatus unknownNCT01261936
- A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543CompletedNCT01238367Phase 1
- Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and InhibitorsCompletedNCT01234545
- Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or BCompletedNCT01228669Phase 1
- A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured PatientsCompletedNCT01228058
- Study Using Plasma for Patients Requiring Emergency SurgeryWithdrawnNCT01221389Phase 4
- Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or BCompletedNCT01220141
- Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia ACompletedNCT01205724Phase 1
- Fibrinogen Concentrate In Children After Cardiac SurgeryCompletedNCT01187225Phase 2
- Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersCompletedNCT01153997Phase 1
- Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) PatientsCompletedNCT01143909Not applicable
- Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male SubjectsCompletedNCT01082406Phase 1
- Modified Ultrafiltration in Cardiac SurgeryCompletedNCT00998647
- Fibrinogen as an Alternative to FFP in Aortic Surgery.CompletedNCT00994045Phase 4
- Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin AmericaCompletedNCT00969319
- Anticoagulant Clinics and Vitamin K AntagonistsCompletedNCT00966290Phase 4
- Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia BCompletedNCT00956345Phase 1
- A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male VolunteersCompletedNCT00951873Phase 1
- Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsCompletedNCT00951405Phase 2
- The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study)CompletedNCT00945542Phase 1/2
- Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and BCompletedNCT00922792Phase 1
- The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding DisordersCompletedNCT00904709Phase 4
- Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia DatabaseCompletedNCT00853086
- Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsCompletedNCT00837356Phase 1
- Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental ExtractionCompletedNCT00816127Not applicable
- Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping InstrumentCompletedNCT00772434
- An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured PatientsWithdrawnNCT00744003
- Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IXCompletedNCT00710619
- Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in GermanyCompletedNCT00697320
- Markers of Defective Membrane Remodelling in Scott-like SyndromesTerminatedNCT00617721
- The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood ClotsStatus unknownNCT00584610Not applicable
- The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood ClotsTerminatedNCT00580424Not applicable
- High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsCompletedNCT00571584Phase 4
- CLUE Study: Connective Tissue Disease Leg Ulcer Etiology StudyCompletedNCT00522002
- Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac SurgeryCompletedNCT00516126
- Dilutional Coagulopathy in Patients Undergoing Elective SurgeryCompletedNCT00493272Phase 1/2
- Recombinant Factor VIIa in Acute Intracerebral HaemorrhageCompletedNCT00426803Phase 2
- PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual CareWithdrawnNCT00377143Phase 4
- Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac SurgeryTerminatedNCT00359398Phase 2
- Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized TrialCompletedNCT00355290Not applicable
- Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to TraumaWithdrawnNCT00323570Phase 3
- Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.TerminatedNCT00288808Phase 1
- Factor VIIa in Acute Intracerebral HaemorrhageCompletedNCT00266006Phase 2
- Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive ProceduresWithdrawnNCT00233246Phase 3
- "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac SurgeryStatus unknownNCT00214656Phase 3
- Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint DiseaseCompletedNCT00212485Not applicable
- Hypercoagulability After Breast Cancer SurgeryCompletedNCT00210197
- Comparison of Three Management Strategies for Post Cardiac Surgery BleedingCompletedNCT00188747Phase 4
- Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)CompletedNCT00168090Phase 4
- Thrombin Generation in NeonatesCompletedNCT00165906
- Use of NovoSeven® in Active Variceal BleedingCompletedNCT00154492Phase 2
- Use of Activated Recombinant Human Factor VII in Cardiac SurgeryTerminatedNCT00154427Phase 2
- Oral Vitamin K for Warfarin Associated CoagulopathyCompletedNCT00143715Phase 3
- Kid Cards: Teaching Kids About MedicinesWithdrawnNCT00127543Not applicable
- Recombinant Factor VIIa in Acute Intracerebral HaemorrhageCompletedNCT00127283Phase 3